Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma: Does Radiation Dose Make a Difference?-Reference-Cited by-同舟云学术

Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma: Does Radiation Dose Make a Difference?

Published:2018-08-20 Issue:24 Volume:36 Page:2566-2567
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Shinde Ashwin¹,Jones Bernard L.¹,Chen Yi-Jen¹,Amini Arya¹

Affiliation:

1. Ashwin Shinde, City of Hope National Cancer Center, Duarte, CA; Bernard L. Jones, University of Colorado School of Medicine, Aurora, CO; and Yi-Jen Chen and Arya Amini, City of Hope National Cancer Center, Duarte, CA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2018.78.6012

Reference6 articles.

1. Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database

2. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases

3. Stereotactic Body Radiotherapy (SBRT) for Operable Stage I Non–Small-Cell Lung Cancer: Can SBRT Be Comparable to Surgery?

4. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment

5. Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Outcome of Stereotactic Body Radiotherapy for Small Hepatocellular Carcinoma Lesions – A Systematic Review and Network Meta-analysis;Clinical Oncology;2023-10

2. Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study;Radiation Oncology;2021-04-21

3. Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiation Therapy Compared With Surgery and Radiofrequency Ablation in Two Patient Cohorts: Metastatic Liver Cancer and Hepatocellular Carcinoma;Clinical Oncology;2021-03

4. Recommendations for radiosurgery and stereotactic ablative radiotherapy terminology to guide clinical and research practices for the medical oncologist, radiation oncologist, and surgeon;Journal of Radiation Oncology;2020-05-15

5. Optimal Stereotactic Body Radiotherapy Dosage For Hepatocellular Carcinoma;2020-02-27